ATE234110T1 - Komponente b als wundheilendes mittel - Google Patents

Komponente b als wundheilendes mittel

Info

Publication number
ATE234110T1
ATE234110T1 AT96914107T AT96914107T ATE234110T1 AT E234110 T1 ATE234110 T1 AT E234110T1 AT 96914107 T AT96914107 T AT 96914107T AT 96914107 T AT96914107 T AT 96914107T AT E234110 T1 ATE234110 T1 AT E234110T1
Authority
AT
Austria
Prior art keywords
component
pct
wound healing
healing agent
sec
Prior art date
Application number
AT96914107T
Other languages
English (en)
Inventor
Francesco Borrelli
Silvia Donini
Fabrizio Martelli
Renato Mastrangeli
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE234110T1 publication Critical patent/ATE234110T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • External Artificial Organs (AREA)
  • Glass Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96914107T 1996-04-24 1996-04-24 Komponente b als wundheilendes mittel ATE234110T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP1996/001702 WO1997039765A1 (en) 1996-04-24 1996-04-24 Component b as cicatrizant
CA002251356A CA2251356A1 (en) 1996-04-24 1996-04-24 Component b as cicatrizant

Publications (1)

Publication Number Publication Date
ATE234110T1 true ATE234110T1 (de) 2003-03-15

Family

ID=25680594

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96914107T ATE234110T1 (de) 1996-04-24 1996-04-24 Komponente b als wundheilendes mittel

Country Status (14)

Country Link
US (1) US5998364A (de)
EP (1) EP0895478B1 (de)
JP (1) JP3882943B2 (de)
AT (1) ATE234110T1 (de)
AU (1) AU727618B2 (de)
CA (1) CA2251356A1 (de)
DE (1) DE69626691T2 (de)
DK (1) DK0895478T3 (de)
EA (1) EA001077B1 (de)
ES (1) ES2188754T3 (de)
IL (1) IL120696A (de)
NO (1) NO320611B1 (de)
WO (1) WO1997039765A1 (de)
ZA (1) ZA973442B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000002579A2 (en) * 1998-07-09 2000-01-20 Applied Research Systems Ars Holding N.V. Component b as angiogenic agent in combination with human growth factors
US7135454B2 (en) 2003-04-16 2006-11-14 Applied Research Systems Ars Holding N.V. Use of SLURP-1 compositions for treating schizophrenia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE53166B1 (en) * 1980-08-05 1988-08-03 Searle & Co Synthetic urogastrone gene,corresponding plasmid recombinants,transformed cells,production thereof and urogastrone expression
IT1257184B (it) * 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale

Also Published As

Publication number Publication date
IL120696A (en) 2001-10-31
DK0895478T3 (da) 2003-06-23
ZA973442B (en) 1998-02-23
AU727618B2 (en) 2000-12-14
EA199800953A1 (ru) 1999-04-29
WO1997039765A1 (en) 1997-10-30
DE69626691T2 (de) 2003-08-14
AU5760596A (en) 1997-11-12
ES2188754T3 (es) 2003-07-01
NO984965L (no) 1998-12-01
JP3882943B2 (ja) 2007-02-21
CA2251356A1 (en) 1997-10-30
NO320611B1 (no) 2005-12-27
IL120696A0 (en) 1997-08-14
NO984965D0 (no) 1998-10-23
EA001077B1 (ru) 2000-10-30
DE69626691D1 (de) 2003-04-17
EP0895478A1 (de) 1999-02-10
US5998364A (en) 1999-12-07
JP2000510436A (ja) 2000-08-15
EP0895478B1 (de) 2003-03-12

Similar Documents

Publication Publication Date Title
ATE254905T1 (de) Verwendung mindestens eines hydroxystilben in einer straffenden zusammensetzung
DE69524682D1 (de) Mittel zur Behandlung von Wunden
ATE285219T1 (de) Rekombinante haarbehandlungsmittel
FR2719768B1 (fr) Utilisation d'extraits de bactéries filamenteuses comme agents cosmétiques contre le vieillissement cutané.
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
HK1037980A1 (en) Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage.
GB9708692D0 (en) Dermal sheath tissue and/or cells derived therefrom in wound healing
ATE234110T1 (de) Komponente b als wundheilendes mittel
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
WO1998030212A3 (de) Verwendung von aminothiazolen zur verbesserung der wundheilung
DE59805246D1 (de) Tissue-faktor zur beeinflussung von gefässbildung
GR3031890T3 (en) Use of topically applied factor xiii for inhibiting hemorrhage.
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
MD980129A (en) Antiherpetic remedy
WO2000032155A3 (en) Skin care compositions containing zinc salts and retinoids
SE9403861D0 (sv) Novel medicinal use
GB9812278D0 (en) Use of a wound dressing in the treatment of acute wounds
UA42335A (uk) Спосіб лікування гнійних ран
UA32315A (uk) Спосіб накладання шкірного шва
GEP20012408B (en) Means for Treatment of Psoriasis
UA32281A (uk) Засіб "регенерин" для зовнішнього лікування гнійних ран і трофічних виразок
AU6664598A (en) Use of curcumin in treatment of psoriasis, inflammation, skin wounds, burns, andeczemas
UA29506C2 (uk) Лікувально-косметичний засіб "фіто-пелоїд"
UA30556A (uk) Спосіб модуляції гоєння ран

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0895478

Country of ref document: EP

REN Ceased due to non-payment of the annual fee